ProStep Rehab Revenue and Competitors

USA

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • ProStep Rehab's estimated annual revenue is currently $54.4M per year.(i)
  • ProStep Rehab's estimated revenue per employee is $297,000

Employee Data

  • ProStep Rehab has 183 Employees.(i)
  • ProStep Rehab grew their employee count by -1% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$354.2M9376%N/AN/A
#2
$4.5M24-14%N/AN/A
#3
$25.9M96-14%N/AN/A
#4
$18M74-16%N/AN/A
#5
$10.8M509%N/AN/A
#6
$32.9M1228%N/AN/A
#7
$187.3M5559%N/AN/A
#8
$417.7M110522%N/AN/A
#9
$25.9M9628%N/AN/A
#10
$108.7M3228%N/AN/A
Add Company

What Is ProStep Rehab?

ProStep Rehabilitation prides itself on revolutionizing post-acute therapy, by providing comprehensive rehabilitation services including physical and occupational therapy, as well as speech-language pathology. ProStep strives to motivate each resident, guiding them through the recovery process and facilitating their return to activities that are meaningful to them. Therapists not only provide technical skill and expertise, but offer inspiration and support through individualized and progressive care. Specialty services listed below are offered at most Extendicare centers.\r\n\r\n Physical Therapy\r\n Fall Prevention\r\n Posture Analysis\r\n Gait Analysis\r\n Joint Protection\r\n Therapeutic Modalities\r\n Wound Care\r\n Pain Management\r\n\r\n Occupational Therapy\r\n Activities of Daily Living\r\n Functional Mobility\r\n Positioning/Splinting\r\n Home Safety Assessment\r\n Dementia Management\r\n Low Vision\r\n Environmental Modification\r\n Lymphedema\r\n Cognitive Training\r\n\r\n Speech-Language Pathology\r\n Communication\r\n Dysphagia\r\n VitalStim©\r\n Cognitive Linguistics

keywords:N/A

N/A

Total Funding

183

Number of Employees

$54.4M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$45.7M1838%N/A
#2
$15M1839%N/A
#3
$71.1M1839%N/A
#4
$45.7M1830%N/A
#5
$15M183-1%N/A